These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 12792754
1. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro. Igawa H, Fujieda S, Kimura Y, Sugimoto C, Tanaka N, Ohtsubo T, Kato Y, Saito H. Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754 [Abstract] [Full Text] [Related]
2. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas. Tsuzuki H, Sunaga H, Ito T, Narita N, Sugimoto C, Fujieda S. Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220 [Abstract] [Full Text] [Related]
3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S, Saga Y, Suzuki N, Fujioka A, Nakagawa F, Fukushima M, Suzuki M. Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [Abstract] [Full Text] [Related]
4. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Fujieda S, Sunaga H, Tsuzuki H, Tanaka N, Saito H. Clin Cancer Res; 1998 Jul; 4(7):1583-90. PubMed ID: 9676830 [Abstract] [Full Text] [Related]
5. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S. Cancer Res; 1995 Apr 15; 55(8):1687-90. PubMed ID: 7536129 [Abstract] [Full Text] [Related]
6. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW. Head Neck; 2004 Aug 15; 26(8):706-15. PubMed ID: 15287038 [Abstract] [Full Text] [Related]
7. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL. J Pathol; 1995 Jun 15; 176(2):183-90. PubMed ID: 7636628 [Abstract] [Full Text] [Related]
8. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Wang MB, Yip HT, Srivatsan ES. Laryngoscope; 2001 Jun 15; 111(6):982-8. PubMed ID: 11404608 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T. Clin Cancer Res; 1995 Sep 15; 1(9):961-4. PubMed ID: 9816067 [Abstract] [Full Text] [Related]
10. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, Haraguchi M, Sumizawa T, Ono M, Kuwano M, Kanzaki T, Akiyama S. Cancer Res; 2002 May 15; 62(10):2834-9. PubMed ID: 12019161 [Abstract] [Full Text] [Related]
11. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines. Koh TY, Park SW, Park KH, Lee SG, Seol JG, Lee DW, Lee CT, Heo DS, Kim KH, Sung MW. Head Neck; 2003 Jan 15; 25(1):44-9. PubMed ID: 12478543 [Abstract] [Full Text] [Related]
12. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Br J Cancer; 1999 Mar 15; 79(7-8):1249-54. PubMed ID: 10098767 [Abstract] [Full Text] [Related]
13. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. Ellis PE, Wong Te Fong LF, Rolfe KJ, Crow JC, Reid WM, Davidson T, MacLean AB, Perret CW. Anticancer Res; 2002 Mar 15; 22(2A):857-61. PubMed ID: 12014662 [Abstract] [Full Text] [Related]
14. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H. J Gastroenterol; 2003 Mar 15; 38(3):229-37. PubMed ID: 12673445 [Abstract] [Full Text] [Related]
15. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line. Supriatno, Harada K, Kawaguchi S, Yoshida H, Sato M. Oncol Rep; 2003 Mar 15; 10(3):527-32. PubMed ID: 12684618 [Abstract] [Full Text] [Related]
16. Expression of basic fibroblast growth factor is associated with a good outcome in patients with squamous cell carcinoma of the esophagus. Nakamura T, Ozawa S, Kitagawa Y, Shih CH, Ueda M, Kitajima M. Oncol Rep; 2005 Sep 15; 14(3):617-23. PubMed ID: 16077964 [Abstract] [Full Text] [Related]
17. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J. Biochem Pharmacol; 2007 Dec 03; 74(11):1555-67. PubMed ID: 17572389 [Abstract] [Full Text] [Related]
18. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM, Yao G. J Cell Physiol; 2003 Dec 03; 197(3):326-35. PubMed ID: 14566962 [Abstract] [Full Text] [Related]
19. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I, Tsukuda M. Oncol Rep; 2004 Feb 03; 11(2):421-6. PubMed ID: 14719078 [Abstract] [Full Text] [Related]
20. Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma. Miwa S, Soeda J, Miyagawa S. Hepatogastroenterology; 2005 Feb 03; 52(65):1398-402. PubMed ID: 16201082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]